IBLHL · IBL HealthCare Limited
Transmission of Annual Report for the Year Ended June 30, 2026
- Filed
- 6 October 2026 at 11:33 am
- Category
- Financials
- Sentiment
- Good
- Impact
- High
AI executive summary
IBL HealthCare Limited reported audited financial results for the year ended June 30, 2026, showing a 7% increase in net revenue to PKR 4,607 million and a 6% rise in profit after tax to PKR 220 million, with earnings per share at Rs. 2.24. The Board opted not to declare a dividend to preserve cash and support strategic investments, alongside scheduling its 29th AGM for October 27, 2026.
Key takeaways
- Net revenue increased 7% YoY to PKR 4,607 million for the year ended June 30, 2026.
- Profit after tax rose 6% YoY to PKR 220 million, translating to an EPS of Rs. 2.24 compared to restated Rs. 2.11 in FY25.
- Gross profit improved 14% to PKR 1,644 million, with gross margins strengthening to 35.7%.
- The Board decided not to declare a dividend for the year to maintain financial stability and conserve cash reserves.
- The 29th Annual General Meeting is scheduled for Tuesday, October 27, 2026.
Filing details
Financial results
Annual · Audited · Standalone · 30 June 2026
Figures in PKR '000
Reporting period
Year
- Income
- 4,607,109 (prior 4,322,471)
- Profit after tax
- 220,402 (prior 208,371)
- EPS
- 2.24 (prior 2.11)
- Decided not to declare a dividend for the year ended June 30, 2026 to conserve cash reserves and fund strategic projects.
- Proposed the re-appointment of A.F. Ferguson & Co., Chartered Accountants as statutory auditors for the year ending June 30, 2027.
- Convened the 29th Annual General Meeting for October 27, 2026.
Dividend and entitlement
- Type
- None
- Notes
- Transmission of Annual Financial Statements with no dividend or entitlement declared.
- #annual report
- #financial results
- #iblhl
- #earnings
- #dividend
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.